Whole-exome  ||| S:0 E:12 ||| JJ
sequencing  ||| S:12 E:23 ||| NN
reveals  ||| S:23 E:31 ||| VBZ
genetic  ||| S:31 E:39 ||| JJ
variability  ||| S:39 E:51 ||| NN
among  ||| S:51 E:57 ||| IN
lung  ||| S:57 E:62 ||| NN
cancer  ||| S:62 E:69 ||| NN
cases  ||| S:69 E:75 ||| NNS
subphenotyped  ||| S:75 E:89 ||| VBN
for  ||| S:89 E:93 ||| IN
emphysema  ||| S:93 E:103 ||| JJ
Lung  ||| S:103 E:108 ||| NNP
cancer  ||| S:108 E:115 ||| NN
continues  ||| S:115 E:125 ||| VBZ
to  ||| S:125 E:128 ||| TO
be  ||| S:128 E:131 ||| VB
a  ||| S:131 E:133 ||| DT
major  ||| S:133 E:139 ||| JJ
public  ||| S:139 E:146 ||| JJ
health  ||| S:146 E:153 ||| NN
challenge  ||| S:153 E:163 ||| NN
in  ||| S:163 E:166 ||| IN
the  ||| S:166 E:170 ||| DT
United  ||| S:170 E:177 ||| NNP
States  ||| S:177 E:184 ||| NNPS
despite  ||| S:184 E:192 ||| IN
efforts  ||| S:192 E:200 ||| NNS
to  ||| S:200 E:203 ||| TO
decrease  ||| S:203 E:212 ||| VB
the  ||| S:212 E:216 ||| DT
prevalence  ||| S:216 E:227 ||| NN
of  ||| S:227 E:230 ||| IN
smoking ||| S:230 E:237 ||| NN
;  ||| S:237 E:239 ||| :
outcomes  ||| S:239 E:248 ||| NNS
are  ||| S:248 E:252 ||| VBP
especially  ||| S:252 E:263 ||| RB
poor  ||| S:263 E:268 ||| JJ
for  ||| S:268 E:272 ||| IN
African-American  ||| S:272 E:289 ||| JJ
patients  ||| S:289 E:298 ||| NNS
compared  ||| S:298 E:307 ||| VBN
to  ||| S:307 E:310 ||| TO
other  ||| S:310 E:316 ||| JJ
races ||| S:316 E:321 ||| NNS
/ ||| S:321 E:322 ||| VBP
ethnicities ||| S:322 E:333 ||| VBN
.  ||| S:333 E:335 ||| .
Chronic  ||| S:335 E:343 ||| FW
obstructive  ||| S:343 E:355 ||| FW
pulmonary  ||| S:355 E:365 ||| FW
disease  ||| S:365 E:373 ||| FW
( ||| S:373 E:374 ||| -LRB-
COPD ||| S:374 E:378 ||| NNP
)  ||| S:378 E:380 ||| -RRB-
co-occurs  ||| S:380 E:390 ||| JJ
with  ||| S:390 E:395 ||| IN
lung  ||| S:395 E:400 ||| NN
cancer  ||| S:400 E:407 ||| NN
frequently ||| S:407 E:417 ||| RB
,  ||| S:417 E:419 ||| ,
but  ||| S:419 E:423 ||| CC
not  ||| S:423 E:427 ||| RB
always ||| S:427 E:433 ||| RB
,  ||| S:433 E:435 ||| ,
suggesting  ||| S:435 E:446 ||| VBG
both  ||| S:446 E:451 ||| DT
shared  ||| S:451 E:458 ||| NN
and  ||| S:458 E:462 ||| CC
distinct  ||| S:462 E:471 ||| JJ
risk  ||| S:471 E:476 ||| NN
factors  ||| S:476 E:484 ||| NNS
for  ||| S:484 E:488 ||| IN
these  ||| S:488 E:494 ||| DT
two  ||| S:494 E:498 ||| CD
diseases ||| S:498 E:506 ||| NNS
.  ||| S:506 E:508 ||| .
To  ||| S:508 E:511 ||| TO
identify  ||| S:511 E:520 ||| VB
germline  ||| S:520 E:529 ||| JJ
genetic  ||| S:529 E:537 ||| JJ
variation  ||| S:537 E:547 ||| NN
that  ||| S:547 E:552 ||| IN
distinguishes  ||| S:552 E:566 ||| NN
between  ||| S:566 E:574 ||| IN
lung  ||| S:574 E:579 ||| NN
cancer  ||| S:579 E:586 ||| NN
in  ||| S:586 E:589 ||| IN
the  ||| S:589 E:593 ||| DT
presence  ||| S:593 E:602 ||| NN
and  ||| S:602 E:606 ||| CC
absence  ||| S:606 E:614 ||| NN
of  ||| S:614 E:617 ||| IN
emphysema ||| S:617 E:626 ||| NN
,  ||| S:626 E:628 ||| ,
we  ||| S:628 E:631 ||| PRP
performed  ||| S:631 E:641 ||| VBD
whole-exome  ||| S:641 E:653 ||| JJ
sequencing  ||| S:653 E:664 ||| NN
on  ||| S:664 E:667 ||| IN
46  ||| S:667 E:670 ||| CD
African-American  ||| S:670 E:687 ||| JJ
lung  ||| S:687 E:692 ||| NN
cancer  ||| S:692 E:699 ||| NN
cases  ||| S:699 E:705 ||| NNS
( ||| S:705 E:706 ||| -LRB-
23  ||| S:706 E:709 ||| CD
with  ||| S:709 E:714 ||| IN
and  ||| S:714 E:718 ||| CC
23  ||| S:718 E:721 ||| CD
without  ||| S:721 E:729 ||| IN
emphysema  ||| S:729 E:739 ||| JJ
frequency  ||| S:739 E:749 ||| NN
matched  ||| S:749 E:757 ||| VBN
on  ||| S:757 E:760 ||| IN
age ||| S:760 E:763 ||| NN
,  ||| S:763 E:765 ||| ,
sex ||| S:765 E:768 ||| NN
,  ||| S:768 E:770 ||| ,
histology  ||| S:770 E:780 ||| NN
and  ||| S:780 E:784 ||| CC
pack  ||| S:784 E:789 ||| NN
years ||| S:789 E:794 ||| NNS
) ||| S:794 E:795 ||| -RRB-
.  ||| S:795 E:797 ||| .
Using  ||| S:797 E:803 ||| VBG
conditional  ||| S:803 E:815 ||| JJ
logistic  ||| S:815 E:824 ||| JJ
regression ||| S:824 E:834 ||| NN
,  ||| S:834 E:836 ||| ,
we  ||| S:836 E:839 ||| PRP
found  ||| S:839 E:845 ||| VBD
6305  ||| S:845 E:850 ||| CD
variants  ||| S:850 E:859 ||| NNS
( ||| S:859 E:860 ||| -LRB-
of  ||| S:860 E:863 ||| IN
168  ||| S:863 E:867 ||| CD
150  ||| S:867 E:871 ||| CD
varying  ||| S:871 E:879 ||| CD
sites ||| S:879 E:884 ||| NNS
)  ||| S:884 E:886 ||| -RRB-
significantly  ||| S:886 E:900 ||| RB
associated  ||| S:900 E:911 ||| VBN
with  ||| S:911 E:916 ||| IN
lung  ||| S:916 E:921 ||| NN
cancer  ||| S:921 E:928 ||| NN
subphenotype  ||| S:928 E:941 ||| NNS
( ||| S:941 E:942 ||| -LRB-
P  ||| S:942 E:944 ||| NNP
â‰¤  ||| S:944 E:946 ||| CD
0.05 ||| S:946 E:950 ||| CD
) ||| S:950 E:951 ||| -RRB-
.  ||| S:951 E:953 ||| .
Next ||| S:953 E:957 ||| JJ
,  ||| S:957 E:959 ||| ,
we  ||| S:959 E:962 ||| PRP
validated  ||| S:962 E:972 ||| VBD
10  ||| S:972 E:975 ||| CD
of  ||| S:975 E:978 ||| IN
these  ||| S:978 E:984 ||| DT
variants  ||| S:984 E:993 ||| NN
in  ||| S:993 E:996 ||| IN
an  ||| S:996 E:999 ||| DT
independent  ||| S:999 E:1011 ||| JJ
set  ||| S:1011 E:1015 ||| NN
of  ||| S:1015 E:1018 ||| IN
612  ||| S:1018 E:1022 ||| CD
lung  ||| S:1022 E:1027 ||| NN
cancer  ||| S:1027 E:1034 ||| NN
cases  ||| S:1034 E:1040 ||| NNS
( ||| S:1040 E:1041 ||| -LRB-
267  ||| S:1041 E:1045 ||| CD
with  ||| S:1045 E:1050 ||| IN
emphysema  ||| S:1050 E:1060 ||| NN
and  ||| S:1060 E:1064 ||| CC
345  ||| S:1064 E:1068 ||| CD
without  ||| S:1068 E:1076 ||| IN
emphysema ||| S:1076 E:1085 ||| CD
)  ||| S:1085 E:1087 ||| -RRB-
from  ||| S:1087 E:1092 ||| IN
the  ||| S:1092 E:1096 ||| DT
same  ||| S:1096 E:1101 ||| JJ
population  ||| S:1101 E:1112 ||| NN
of  ||| S:1112 E:1115 ||| IN
inference  ||| S:1115 E:1125 ||| NN
as  ||| S:1125 E:1128 ||| IN
the  ||| S:1128 E:1132 ||| DT
sequenced  ||| S:1132 E:1142 ||| JJ
cases ||| S:1142 E:1147 ||| NNS
.  ||| S:1147 E:1149 ||| .
We  ||| S:1149 E:1152 ||| PRP
found  ||| S:1152 E:1158 ||| VBD
one  ||| S:1158 E:1162 ||| CD
variant  ||| S:1162 E:1170 ||| NNS
that  ||| S:1170 E:1175 ||| WDT
was  ||| S:1175 E:1179 ||| VBD
significantly  ||| S:1179 E:1193 ||| RB
associated  ||| S:1193 E:1204 ||| VBN
with  ||| S:1204 E:1209 ||| IN
lung  ||| S:1209 E:1214 ||| NN
cancer  ||| S:1214 E:1221 ||| NN
subphenotype  ||| S:1221 E:1234 ||| NN
in  ||| S:1234 E:1237 ||| IN
the  ||| S:1237 E:1241 ||| DT
validation  ||| S:1241 E:1252 ||| JJ
sample ||| S:1252 E:1258 ||| NN
.  ||| S:1258 E:1260 ||| .
These  ||| S:1260 E:1266 ||| DT
findings  ||| S:1266 E:1275 ||| NNS
contribute  ||| S:1275 E:1286 ||| VBP
to  ||| S:1286 E:1289 ||| TO
teasing  ||| S:1289 E:1297 ||| VB
apart  ||| S:1297 E:1303 ||| RB
shared  ||| S:1303 E:1310 ||| VBN
genetic  ||| S:1310 E:1318 ||| JJ
factors  ||| S:1318 E:1326 ||| NNS
from  ||| S:1326 E:1331 ||| IN
independent  ||| S:1331 E:1343 ||| JJ
genetic  ||| S:1343 E:1351 ||| JJ
factors  ||| S:1351 E:1359 ||| NNS
for  ||| S:1359 E:1363 ||| IN
lung  ||| S:1363 E:1368 ||| NN
cancer  ||| S:1368 E:1375 ||| NN
and  ||| S:1375 E:1379 ||| CC
COPD ||| S:1379 E:1383 ||| NNP
.  ||| S:1383 E:1385 ||| .
